Findings aimed at tailoring treatment to patients’ specific anatomy

The National Institutes of Health’s National Institute on Drug Abuse (NIDA) has awarded $3.7 million to Indiana University researchers to investigate the complex relationship between ADHD medications and serious substance use problems among vulnerable youth and young adults. The study aims to fill critical gaps in understanding how ADHD medications impact the risk of serious substance use problems by analyzing nationwide healthcare data of over 3.3 million young people (ages 9-29) enrolled in Medicaid who received an ADHD diagnosis.

More than half of survivors of the Sudan Ebola virus still suffer serious health problems two years post-infection and the virus can persist in semen and breast milk for months after recovery, according to the first study examining the virus’s long-term effects.

Two researchers from Boston University Chobanian & Avedisian School of Medicine were recently honored for their work in the treatment of war-related posttraumatic stress disorder (PTSD) at the Trauma Recovery Center at Hebrew University of Jerusalem.

 

Denise M. Sloan, PhD, professor of psychiatry at the school and senior psychologist clinician investigator, Behavioral Science Division, National Center for PTSD at VA Boston Healthcare System, along with Brian P. Marx, PhD, professor of psychiatry and a deputy director at the National Center for PTSD, VA Boston Healthcare System, have been working with clinicians in Israel to help survivors of the Oct. 7, 2023 attack. They have helped train Trauma Recovery Center staff to deliver a brief treatment called Written Exposure Therapy (WET) that they developed.

The Bronchiectasis and NTM Association announced today that two abstracts using Bronchiectasis and NTM Research Registry data were presented at the European Respiratory Society Congress, held September 27-October 1, 2025, in Amsterdam, Netherlands.